The approval is for both a 3 milliliter (mL) single-patient-use prefilled pen and a 10 milliliter ... The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three ...

This disposable insulin pen is to be used for the treatment of ... the name of the parent company was changed globally from sanofi-aventis to Sanofi in May 2011.On 9 October 2012, Sanofi India ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

On February 14, 2025, the U.S. Food and Drug Administration (“FDA”) approved Sanofi-Aventis ... pen and a 10 mL multiple-dose vial. Sanofi’s MERILOG™ is now the first insulin aspart ...

“Merilog, a rapid-acting human insulin analog ... The FDA granted approval of Merilog to Sanofi (SNY)-Aventis U.S. Published first on TheFly – the ultimate source for real-time, market ...

Sanofi-Aventis' Merilog version ... options for costly treatments, like insulin." Merilog has been cleared in a 3ml single-patient-use prefilled pen, and a 10ml multiple-dose vial should be ...

Merilog (insulin-aspart-szjj, Sanofi-Aventis U.S.) was approved as biosimilar ... The approval applies to both a single-patient-use prefilled three mL pen and a 10 mL multi-dose vial.

(RTTNews) - The U.S. Food and Drug Administration announced that Sanofi-Aventis U.S ... use prefilled pen and a 10 mL multiple-dose vial. As a rapid-acting human insulin, Merilog helps to lower ...

(Image Credits: Pixabay) The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart ... of Merilog to Sanofi-Aventis U.S. LLC.